WHO Declares Hantavirus Cruise Ship Outbreak Officially Over
The World Health Organization (WHO) has officially announced that the harrowing hantavirus outbreak that struck passengers aboard a South Atlantic cruise ship has come to an end.
The declaration was made by WHO Director-General Dr. Tedros Adhanom Ghebreyesus after the last remaining individual who was being monitored for potential exposure successfully completed their isolation. The international outbreak ultimately infected 13 people and claimed three lives.
The source of the outbreak was traced back to the MV Hondius, a Dutch-flagged polar exploration vessel that departed from Ushuaia, Argentina, on April 1st. The ship mapped a route across remote islands in the South Atlantic Ocean, including Tristan da Cunha, before charting a course north toward Europe.
According to initial reports, the first two individuals to contract the illness had previously traveled through Argentina, Chile, and Uruguay on a bird-watching excursion. This trip included stops at specific wilderness locations where the particular rat species known to harbor the virus was actively present.
The multi-national response required an aggressive tracking operation to contain the pathogen's footprint. Health authorities across 33 different countries and territories successfully traced and monitored more than 650 close contacts.
What is Hantavirus?
The maritime outbreak involved the Andes strain of the virus, a particularly dangerous and rare variant of hantavirus that typically circulates within specific regions of Argentina and Chile.
While typical hantaviruses are entirely zoonotic, meaning they only jump from animals to humans, the Andes variant carries a unique, terrifying distinction. It stands as the only known hantavirus strain capable of spreading directly between humans through close, prolonged contact. Health experts believe this specific human-to-human transmission is what allowed the virus to take hold among those living in the confined quarters of the cruise liner.
The virus typically targets the respiratory and gastrointestinal systems. Victims generally experience initial symptoms such as fever, extreme fatigue, severe headaches, muscle aches, stomach pain, vomiting, and diarrhea.
These indicators usually present themselves anywhere between one and eight weeks following initial exposure. Because the incubation period can drag on for more than a month, health officials were forced to mandate an exceptionally long isolation window for the ship's passengers.
In its most severe stages, the pathogen quickly attacks the respiratory tract, causing violent coughing, intense shortness of breath, and rapid fluid accumulation in the lungs. Managing the disease is incredibly difficult for medical teams; there are currently no approved vaccines or targeted antiviral treatments available on the global market. Instead, doctors must rely almost exclusively on supportive hospital care to keep patients stabilized.
The physical crisis on the ship wrapped up in May when the remaining passengers, who did not require emergency medical evacuation, finally disembarked in Tenerife, Spain, before being flown back to their respective home countries. The MV Hondius then sailed to Rotterdam in the Netherlands, docking on May 18th. Following an intense deep cleaning and chemical disinfection process, maritime authorities cleared the vessel to return to open waters on May 30th.
Even though this specific cruise ship threat has been neutralized, global health leaders warn against complacency. The WHO is leveraging the data from this incident to better prepare for future mutations or flare-ups.
“Andes virus and other hantaviruses are still a public health risk for South America, and some other endemic areas..." warned WHO medical officer Dr. Diana Rojas Alvarez during a press briefing. "What we need to continue doing is to keep monitoring this virus, keep preparing for further spread."
To achieve this, the global health body is launching a massive scientific initiative to map the pathogen's behavior.
“We are also coordinating a study involving 21 countries to understand how the disease develops, which will support the development of diagnostics, therapeutics and vaccines for future outbreaks,” Dr. Tedros stated.
